Evidence map›Paper›PMID 40008534›Full record

ArticleJournal of cellular and molecular medicine2025

Constructing a Prognostic Model for Subtypes of Colorectal Cancer Based on Machine Learning and Immune Infiltration-Related Genes.

Yue Wen, Jing Liao, Chunyan Lu, Lan Huang, Yanling Ma

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yue WenDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Jing LiaoDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Chunyan LuDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Lan HuangDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Yanling MaDepartment of Gastrointestinal Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.ORCID 0009-0005-0287-956X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study constructed a prognostic model combining machine learning-based immune infiltration-related genes in each CRC subtype. We used publicly accessible gene expression data and clinical information on colorectal cancer patients. Integrated bioinformatics analysis was used for the identification of immune-wise genes. Machine learning algorithms, like LASSO regression and random forest, were utilised to identify the most important genes that may serve as predictors for patient prognosis. Univariate Cox regression, consensus clustering as well as machine learning algorithms were conducted to construct a prognostic risk scoring model. Analysis of functional enrichment, immune infiltration analyses and copy number variations as well as mutational burdens was performed and validated at the single-cell level. A machine learning-based model is designed with good predictive power-an area under the receiver operating characteristic curve (AUC-ROC) of C-index in cross-validation. The model also achieved good calibration and discrimination ability to stratify patients into high- and low-risk groups with a statistically significant difference in OS (p < 0.05). We have integrated multiple types of gene network features into machine learning systems based on the characteristics of integrating networks with Multi-Expense Learning algorithms, and we propose a robust approach for predicting CRC molecular subtype patient survival. This model could potentially steer personalised treatment strategies and ameliorate outcomes in patients. Although validation in other cohorts and clinical situations is necessary, it may be useful.

Indexed as

Biomarkers, TumorColorectal NeoplasmsMachine LearningAlgorithmsComputational BiologyDNA Copy Number VariationsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMalePrognosisROC CurveBiomarkers, Tumorcolorectal cancercore genesmachine learningprognostic analysis

Identifiers

PMID40008534
PMCPMC11862891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.